Dover Corporation (DOV) Reached the 52-Week High of $73.74
The prices of Dover Corporation (DOV) shares have reached $73.74, which is 0.2% off the 52-week high of $73.92.
Dover Corporation was incorporated in 1947 in the State of Delaware. Dover Corporation has a market cap of $12.88 billion; its shares were traded at around $73.74 with a P/E ratio of 16.2866 and P/S ratio of 1.6745. The dividend yield of Dover Corporation stocks is 1.85%. Dover Corporation had an annual average earnings growth of 12.3% over the past 10 years. GuruFocus rated Dover Corporation the business predictability rank of 3-star.
On January 24, 2013 Dover announced that for the fourth quarter ended December 31, 2012, revenue was $2.0 billion, an increase of 6% over the prior year period. The revenue increase was driven by organic growth of 2% and a 5% increase from acquisitions, offset in part by a 1% unfavorable impact from foreign exchange. Earnings from continuing operations were $208.2 million, or $1.16 diluted earnings per share (EPS), compared to $197.3 million, or $1.05 EPS, in the prior year period, representing increases in earnings from continuing operations and EPS of 6% and 10%, respectively. Excluding the impact of tax benefits of $0.07 EPS recognized in the current quarter and $0.03 EPS recognized in the prior year period, adjusted EPS from continuing operations for the fourth quarter of 2012 was $1.09, reflecting an increase of 7% over an adjusted EPS of $1.02 in the prior year period.
Vice President William Spurgeon sold 25,492 shares of DOV stock on February 7, 2013 at the average price of 70.88. William Spurgeon owns at least 33,796 shares after this. The price of the stock has increased by 4.03% since.
Eli Lilly and Company (LLY) Reached the 52-Week High of $55.16
The prices of Eli Lilly and Company (LLY) shares have reached $55.16, which is 1.0% off the 52-week high of $55.7.
Eli Lilly and Company was incorporated in 1901 in Indiana for the drug manufacturing business founded in Indianapolis, Indiana, in 1876. Eli Lilly and Company has a market cap of $62.57 billion; its shares were traded at around $55.16 with a P/E ratio of 15.0602 and P/S ratio of 2.7263. The dividend yield of Eli Lilly and Company stocks is 3.55%. Eli Lilly and Company had an annual average earnings growth of 6.2% over the past 10 years. GuruFocus rated Eli Lilly and Company the business predictability rank of 2.5-star.
On January 29, 2013 Eli Lilly and Company announced financial results for the fourth quarter and full year of 2012. Fourth quarter earnings per share were $0.74 (reported), or $0.85 (non-GAAP). Full-year 2012 revenue declined 7 percent to $22.6 billion. Full-year 2012 earnings per share totaled $3.66 (reported), or $3.39 (non-GAAP).
Year 2013 guidance increased by $0.07 per share to reflect the estimated benefit from the delayed enactment of the American Taxpayer Relief Act of 2012. Year 2013 earnings per share are now expected to be in the range of $4.10 to $4.25 (reported), or $3.82 to $3.97 (non-GAAP).
SVP and President., Lilly Oncology Susan Mahony sold 10,000 shares of LLY stock on October 24, 2012 at the average price of $50.45. Susan Mahony owns at least 28,141 shares after this. The price of the stock has increased by 9.34% since.
Check out the complete list of 52-Week Highs.